
Illumatox Aesthetic Studio
Neenah, WI
For under-eye shadows and hollows.

Neenah, WI

Miami, FL

Pensacola, FL

Hallandale Beach, FL

Turlock, CA

Rice Lake, WI

Village of Clarkston, MI

Tulsa, OK

Kaysville, UT

Woodbury, MN

Chattanooga, TN

Rye, NY

Mequon, WI

Bakersfield, CA


Monterey, CA

Miami, FL

Bondurant, IA

Layton, UT

Cypress, CA

Beverly Hills, CA

Boca Raton, FL

Kingsport, TN

Menomonee Falls, WI
Showing 24 of 42 clinics
Estimates are for educational purposes only. Actual pricing varies by clinic, geography, and treatment area. Consult a verified clinic for a personalized quote.
Tear Trough Filler is generally considered safe when performed by a trained, licensed provider. Common side effects include temporary bruising, swelling, or redness at the injection site. Serious complications are rare but possible. Always consult a board-certified provider and disclose your full medical history before treatment.
Tear trough filler is a soft hyaluronic acid gel placed in the hollow between the lower eyelid and cheek to remove the shadow that makes you look tired. It changes shadow, not skin colour and not eye bags. Typical dose is 0.3 to 0.5 mL per eye, lasting 9 to 15 months.
The tear trough is a groove created by a ligament that tethers skin to the orbital rim. As the fat pad beneath it (the SOOF) shrinks, the groove deepens and casts a shadow. Filler placed deep, on bone, softens that groove. It does not lighten pigmented dark circles, and adding volume beside a true fat bag usually makes the bag look worse. Preferred products are soft, low-water-binding HA fillers such as Restylane, Belotero and Restylane Eyelight. Juvederm Voluma and Ultra are avoided here because they draw water and cause persistent puffiness, and Sculptra and Radiesse should never be used under the eye because they cannot be dissolved. Volbella XC, Eyelight and Belotero Balance (+) hold FDA approval for infraorbital hollowing; other fillers used here are off-label.
The main options are hyaluronic acid filler (0.3 to 0.5 mL per eye, lasting 9 to 15 months; Volbella XC and Restylane Eyelight are FDA-approved here), cheek filler to support the lid-cheek junction, PRP or PRF for skin quality, laser or peels for dark circles, and lower blepharoplasty for fat bags.
Choosing correctly starts with identifying what your under-eye problem actually is. A hollow that casts a shadow responds to filler. Pigmented dark circles are melanin, not shadow, and need topicals, peels or laser instead. Prolapsed orbital fat - real bags - gets worse with filler and needs surgery. Crepey skin needs energy-based treatment or PRF, not volume. Many people have a combination, and the honest answer is often that filler will address only part of it. Whatever the plan, treat the cheeks first: restoring midface support frequently reduces or removes the tear trough hollow without injecting near the eye at all. Under-eye filler remains the highest-risk area on the face, with Tyndall discoloration, long-lasting swelling and rare vascular events all documented.
Tear trough filler typically lasts 6 to 18 months. Restylane averages 9 to 12 months, Belotero Balance 6 to 9, Juvederm Volbella XC 9 to 12, and Restylane Eyelight 9 to 12. The under-eye barely moves, so filler here usually outlasts the same product placed in the lips.
Longevity here is not straightforwardly good news. Hyaluronic acid placed deep against the orbital rim can persist beyond its useful cosmetic effect and has been detected on imaging years after injection, which is why layering fresh product on top of old is a common route to permanent-looking puffiness. Conservative maintenance means 0.3 to 0.5 mL per eye at 9 to 15 month intervals, and many experienced injectors now advise periodically dissolving everything to reassess your true baseline anatomy. Restylane Eyelight, Juvederm Volbella XC and Belotero Balance are FDA-approved for infraorbital hollowing. New puffiness appearing months after treatment, particularly with pain or redness, should be reviewed promptly rather than assumed to be normal.
Tear trough filler is safe in experienced hands, but it is the highest-risk filler area on the face. The under-eye sits beside vessels connected to the eye, so injection here carries a rare but real risk of vascular occlusion and vision loss. Choose an injector who treats this area routinely.
The realistic complications are cosmetic, not catastrophic: prolonged puffiness because HA draws in water, visible lumps, the Tyndall effect (a bluish tinge from filler placed too superficially, most common under the eyes), and over-filling that can persist for months. These are managed by using a blunt cannula rather than a sharp needle, staying conservative at roughly 0.3 to 0.5 mL per eye, and choosing low-water-binding products designed for the area. Sculptra and Radiesse should never be used here: they cannot be dissolved, and an inflamed nodule under the eye that cannot be removed is a long-term problem. Blanching, disproportionate pain, mottled skin, or any change in vision is an emergency requiring immediate hyaluronidase, not a wait-and-see.
Common side effects of tear trough filler are swelling, bruising, tenderness and temporary lumpiness, plus three problems specific to this area: the Tyndall effect, persistent puffiness, and filler migration. Tyndall is a bluish-grey cast from filler placed too superficially and does not fade on its own. Rare but serious: vascular occlusion and, very rarely, blindness.
Swelling peaks at 24 to 72 hours and mostly resolves within a week, though subtle puffiness can linger to four weeks. The under-eye swells more, and for longer, than any other filler area. The problems that persist are the ones worth understanding: the Tyndall effect will not fade with time and must be dissolved; over-filling produces a puffy ridge that can attract more water over months; and swelling appearing weeks or months later can signal a biofilm infection or inflammatory reaction and needs prompt evaluation. Delayed-onset nodules sometimes follow a viral illness or vaccination. All hyaluronic acid complications here respond to hyaluronidase, often within 6 to 24 hours.